Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients.

Bourdeaux, Christophe;Darwish, A;Jamart, Jacques;Tri, T T;Reding, Raymond;et.al.
(2007) American Journal of Transplantation — Vol. 7, n° 2, p. 440-447 (2007)

Files

10802.pdf
  • Restricted Access
  • Adobe PDF
  • 100.78 KB

Details

Authors
  • Bourdeaux, ChristopheUCLouvain
    Author
  • Darwish, A
    Author
  • Jamart, JacquesUCLouvain
    Author
  • Tri, T T
    Author
  • Lerut, JanUCLouvain
    Author
  • Otte, Jean-BernardUCLouvain
    Author
  • Sokal, EtienneUCLouvain
    Author
  • de Ville de Goyet, JeanUCLouvain
    Author
  • Reding, RaymondUCLouvain
    Author
Show more
Abstract
Timely access to a living donor (LD) reduced pretransplant mortality in pediatric liver transplantation (LT). We hypothesized that this strategy may provide better posttransplant outcome. Between July 1993 and April 2002, 235 children received a primary LT from a LD (n = 100) or a deceased donor (DD) (n = 135). Demographic, surgical and immunological variables were compared, and respective impact on posttransplant complications was studied using a multivariate analysis. Five-year patient survival rates were 92% and 85% for groups LD and DD, respectively (p = 0.181), the corresponding graft survival rates being 89% and 77% (p = 0.033). At multivariate analysis: (1) type of donor (DD) was correlated with higher rate of artery thrombosis (p < 0.012); (2) biliary complication rate at 5 years was 29% and 23% for groups LD and DD, respectively (p = 0.451); (3) lower acute rejection incidence could be correlated with type of donor (DD) (p = 0.001), and immunosuppressive therapy (tacrolimus) (p < 0.001). We conclude that (1) according to the multivariate analysis, LT with LD provided similar patient and graft outcome, when compared to DD; (2) a higher rate of artery thrombosis and a lower rate of rejection were observed in group DD; (3) this study confirms the efficacy of tacrolimus for immunoprophylaxis, whatever the type of organ donor is.
Affiliations

Citations

Bourdeaux, C., Darwish, A., Jamart, J., Tri, T. T., Janssen, M., Lerut, J., Otte, J.-B., Sokal, E., de Ville de Goyet, J., & Reding, R. (2007). Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. American Journal of Transplantation, 7(2), 440-447. https://doi.org/10.1111/j.1600-6143.2006.01626.x (Original work published 2007)